← Back to Search

Behavioural Intervention

Blood Flow Restriction Training for Muscle Strength in Healthy Individuals

N/A
Recruiting
Led By Hugo Pereira, PhD
Research Sponsored by University of Oklahoma
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up start and end of the protocol
Awards & highlights

Study Summary

This trial will compare regular resistance training with resistance training done with restricted blood flow to see if it increases muscle strength and size. Results will provide insight into a promising new muscle building method.

Who is the study for?
This trial is for healthy individuals interested in participating in a study comparing different resistance training methods. Specific eligibility criteria are not provided, but typically participants must be generally healthy without major medical conditions.Check my eligibility
What is being tested?
The study is testing the effectiveness of resistance training with blood flow restriction against two types of regular resistance training. The goal is to see which method better increases muscle strength and size.See study design
What are the potential side effects?
While specific side effects are not listed, typical risks may include muscle soreness, fatigue, and potential discomfort from the blood flow restriction technique.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 sessions (up to 6 weeks)
This trial's timeline: 3 weeks for screening, Varies for treatment, and 10 sessions (up to 6 weeks) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Force
Secondary outcome measures
Body composition

Trial Design

3Treatment groups
Experimental Treatment
Group I: Group 3Experimental Treatment1 Intervention
Conventional strength training using low loads
Group II: Group 2Experimental Treatment1 Intervention
Conventional strength training using high loads
Group III: Group 1Experimental Treatment1 Intervention
Strength training associated with blood flow restriction

Find a Location

Who is running the clinical trial?

University of OklahomaLead Sponsor
455 Previous Clinical Trials
97,550 Total Patients Enrolled
Hugo Pereira, PhDPrincipal InvestigatorUniversity of Oklahoma
2 Previous Clinical Trials
100 Total Patients Enrolled

Media Library

Blood flow restriction (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05863039 — N/A
Healthy Subjects Research Study Groups: Group 3, Group 1, Group 2
Healthy Subjects Clinical Trial 2023: Blood flow restriction Highlights & Side Effects. Trial Name: NCT05863039 — N/A
Blood flow restriction (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05863039 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What qualifications are necessary for individuals to be accepted in this experiment?

"To become a participant in this experiment, individuals must be of sound health and between the ages of 18 to 50. 60 people are sought for inclusion in this study."

Answered by AI

Is this experimental protocol open to individuals who are over 35 years of age?

"The age range for admission into this trial is 18 to 50, as outlined by the inclusion criteria."

Answered by AI

Are any new participants being accepted for this research project?

"Affirmative. Evidence on clinicaltrials.gov indicates that this medical experiment, originally posted on June 1st 2023, is actively recruiting volunteers. Around 60 participants must be recruited from a single centre."

Answered by AI

Are there any restrictions as to how many individuals are currently receiving treatment in the research project?

"Affirmative. According to the information located on clinicaltrials.gov, this research trial is currently recruiting participants; it was first posted in June 1st 2023 and recently updated on May 8th of that same year. There are 60 individuals sought for enrollment at a single medical centre."

Answered by AI

Who else is applying?

What site did they apply to?
University of Oklahoma
What portion of applicants met pre-screening criteria?
Met criteria

Why did patients apply to this trial?

I don't have Crohn's or UC? I used to donate plasma and I love to help further medical research and technology.
PatientReceived 1 prior treatment
~26 spots leftby May 2025